Article: Fosamax being shipped to pharmacies nationwide.

WEST POINT, Pa.--(BUSINESS WIRE)--Oct. 17, 1995--Fosamax (alendronate sodium), a new nonhormonal medicine for the treatment of osteoporosis in women after menopause, is now available in pharmacies throughout the United States, Merck & Co. Inc. announced Tuesday.

A breakthrough medicine, Fosamax was cleared for marketing by the U.S. Food and Drug Administration less than three weeks ago.

We began shipping Fosamax to local pharmacies last week to ensure that it would be available as quickly as possible as a treatment option for women with this potentially debilitating bone-weakening disorder, said Robert J. Glaser, senior vice president, Osteoporosis, at Merck.

...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!